T-box transcription factors are crucial developmental regulators in all multicellular animals, and they have been implicated in a variety of human diseases and cancers. Despite their importance, few direct targets of T-box factors have been identified. C. elegans TBX-2 is a member of the Tbx2 sub-family of T-box factors, which in other species includes both transcriptional activators and repressors, and it is required for development of anterior pharyngeal muscles. We are interested in determining if TBX-2 is a transcriptional activator or repressor, and in identifying TBX-2 targets to characterize its molecular mechanism. To identify targets of TBX-2, we compared mRNA expression levels in wild-type and hypomorphic
tbx-2(
bx59) mutant embryos using Affymetrix microarrays. Of 19,885 genes examined, we found 980 mRNAs that were significantly up-regulated in
tbx-2(
bx59) and 175 mRNAs that were significantly down-regulated. We analyzed a subset of these differentially expressed genes and found the gene D2096.6 is directly repressed by TBX-2 at a variant T-box binding site in its promoter. Our previous genetic evidence suggests TBX-2 function is SUMOylation dependent, as reduction of the SUMO-conjugating enzyme UBC-9 produces pharyngeal phenotypes similar to loss of TBX-2. Consistent with these results we see that
ubc-9(RNAi) causes over expression of D2096.6 similar to what we have observed in
tbx-2 mutants. By comparing mRNA expression levels in wild-type and
tbx-2(
bx59) mutant embryos we have identified the first direct target of TBX-2 in C. elegans. Our results suggest TBX-2 functions as a transcriptional repressor whose function is dependent on SUMOylation. We are identifying additional TBX-2 targets among the differentially expressed genes using bioinformatic techniques.